{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.38, "earningsTimestamp": 1667201087, "earningsTimestampStart": 1667201087, "earningsTimestampEnd": 1667201087, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "openInterest": 0, "epsTrailingTwelveMonths": -0.04, "epsForward": -0.05, "epsCurrentYear": -0.04, "priceEpsCurrentYear": -9.5, "sharesOutstanding": 197203008, "bookValue": 0.031, "fiftyDayAverage": 0.3883, "fiftyDayAverageChange": -0.008300006, "fiftyDayAverageChangePercent": -0.021375243, "twoHundredDayAverage": 0.4068625, "twoHundredDayAverageChange": -0.026862502, "twoHundredDayAverageChangePercent": -0.066023536, "marketCap": 74975144, "forwardPE": -7.6, "priceToBook": 12.258064, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1407801600000, "priceHint": 4, "marketState": "PRE", "exchange": "ASX", "shortName": "ORTHOCELL FPO", "longName": "Orthocell Limited", "messageBoardId": "finmb_54227224", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683782849, "regularMarketDayHigh": 0.38, "regularMarketDayRange": "0.38 - 0.38", "regularMarketDayLow": 0.38, "regularMarketVolume": 58081, "regularMarketPreviousClose": 0.38, "bid": 0.38, "ask": 0.385, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.38, "averageDailyVolume3Month": 108938, "averageDailyVolume10Day": 66393, "fiftyTwoWeekLowChange": 0.07999998, "fiftyTwoWeekLowChangePercent": 0.2666666, "fiftyTwoWeekRange": "0.3 - 0.505", "fiftyTwoWeekHighChange": -0.125, "fiftyTwoWeekHighChangePercent": -0.24752475, "fiftyTwoWeekLow": 0.3, "fiftyTwoWeekHigh": 0.505, "symbol": "OCC.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building 191", "address2": "Murdoch University South Street", "city": "Murdoch", "state": "WA", "zip": "6150", "country": "Australia", "phone": "61 8 9360 2888", "fax": "61 8 9360 2899", "website": "https://orthocell.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.", "age": 52, "title": "Exec. Chairman", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 150000, "fmt": "150k", "longFmt": "150,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul Frederick Anderson", "age": 56, "title": "CEO, MD & Exec. Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 531045, "fmt": "531.04k", "longFmt": "531,045"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leslie  Wise J.D.", "title": "Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 70927, "fmt": "70.93k", "longFmt": "70,927"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Nicole Jane Telford", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alex  McHenry", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Ming Hao  Zheng", "title": "Chief Scientific Officer and Member of Medical & Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICD", "age": 59, "title": "Company Sec.", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}